TOVX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Theriva Biologics Inc (TOVX).


$4.87M Market Cap.

As of 03/06/2025 5:00 PM ET (MRY) • Disclaimer

TOVX Market Cap. (MRY)


TOVX Shares Outstanding (MRY)


TOVX Assets (MRY)


Total Assets

$35.35M

Total Liabilities

$16.29M

Total Investments

$0

TOVX Income (MRY)


Revenue

$0

Net Income

-$25.65M

Operating Expense

$26.35M

TOVX Cash Flow (MRY)


CF Operations

-$16.94M

CF Investing

-$1.00K

CF Financing

$5.50M

TOVX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

TOVX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$35,352,000 (-35.98%)

$55,219,000 (-23.16%)

$71,861,000 (2.13%)

$70,365,000 (736.68%)

Assets Current

$16,281,000 (-40.59%)

$27,403,000 (-39.80%)

$45,520,000 (-33.89%)

$68,858,000 (767.89%)

Assets Non-Current

$19,071,000 (-31.44%)

$27,816,000 (5.60%)

$26,341,000 (1647.91%)

$1,507,000 (216.60%)

Goodwill & Intangible Assets

$0 (0%)

$5,700,000 (3.17%)

$5,525,000 (0%)

$0 (0%)

Shareholders Equity

$19,067,000 (-48.42%)

$36,963,000 (-28.68%)

$51,830,000 (-20.76%)

$65,408,000 (1472.10%)

Property Plant & Equipment Net

$1,542,000 (-29.30%)

$2,181,000 (41.26%)

$1,544,000 (4.04%)

$1,484,000 (227.59%)

Cash & Equivalents

$11,705,000 (-49.72%)

$23,279,000 (-44.42%)

$41,885,000 (-37.79%)

$67,325,000 (981.18%)

Accumulated Other Comprehensive Income

-$1,178,000 (-3781.25%)

$32,000 (104.71%)

-$679,000 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$859,000 (11.56%)

$770,000 (-15.85%)

$915,000 (74.62%)

$524,000 (-40.86%)

Accumulated Retained Earnings (Deficit)

-$334,971,000 (-8.29%)

-$309,318,000 (-6.31%)

-$290,969,000 (-7.26%)

-$271,284,000 (-9.35%)

Tax Assets

$3,228,000 (78.15%)

$1,812,000 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$2,376,000 (31.13%)

$1,812,000 (11.99%)

$1,618,000 (0%)

$0 (0%)

Total Debt

$1,565,000 (-27.34%)

$2,154,000 (28.14%)

$1,681,000 (10.09%)

$1,527,000 (222.83%)

Debt Current

$600,000 (9.09%)

$550,000 (101.47%)

$273,000 (120.16%)

$124,000 (-56.79%)

Debt Non-Current

$965,000 (-39.84%)

$1,604,000 (13.92%)

$1,408,000 (0.36%)

$1,403,000 (654.30%)

Total Liabilities

$16,285,000 (4.92%)

$15,522,000 (-10.26%)

$17,297,000 (248.94%)

$4,957,000 (57.27%)

Liabilities Current

$7,585,000 (12.57%)

$6,738,000 (-4.56%)

$7,060,000 (98.65%)

$3,554,000 (19.82%)

Liabilities Non-Current

$8,700,000 (-0.96%)

$8,784,000 (-14.19%)

$10,237,000 (629.65%)

$1,403,000 (654.30%)

TOVX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$7,396,000 (3.88%)

$7,120,000 (-27.77%)

$9,858,000 (52.27%)

$6,474,000 (28.73%)

Research & Development Expense

$12,031,000 (-15.93%)

$14,311,000 (22.08%)

$11,723,000 (50.29%)

$7,800,000 (52.02%)

Operating Expenses

$26,346,000 (22.93%)

$21,431,000 (-0.70%)

$21,581,000 (51.19%)

$14,274,000 (40.49%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

-$1,640,000 (-15.09%)

-$1,425,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$25,653,000 (-39.81%)

-$18,349,000 (6.79%)

-$19,685,000 (-37.97%)

-$14,268,000 (-41.04%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

-$1,000 (98.63%)

Net Income

-$25,653,000 (-39.81%)

-$18,349,000 (6.79%)

-$19,685,000 (-37.98%)

-$14,267,000 (-42.06%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$340,000 (-96.19%)

$8,922,000 (254.89%)

Net Income Common Stock

-$25,653,000 (-39.81%)

-$18,349,000 (8.37%)

-$20,025,000 (13.64%)

-$23,189,000 (-84.67%)

Weighted Average Shares

$1,348,126 (-91.63%)

$16,107,014 (5.09%)

$15,327,328 (25.76%)

$12,187,504 (541.06%)

Weighted Average Shares Diluted

$1,348,126 (-91.63%)

$16,107,014 (5.09%)

$15,327,328 (25.76%)

$12,187,504 (541.06%)

Earning Before Interest & Taxes (EBIT)

-$25,653,000 (-28.34%)

-$19,989,000 (5.31%)

-$21,110,000 (-47.96%)

-$14,267,000 (-42.06%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$26,346,000 (-22.93%)

-$21,431,000 (0.70%)

-$21,581,000 (-51.19%)

-$14,274,000 (-40.49%)

TOVX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$1,000 (99.50%)

-$202,000 (95.40%)

-$4,396,000 (-31300.00%)

-$14,000 (-55.56%)

Net Cash Flow from Financing

$5,496,000 (779.36%)

$625,000 (132.38%)

-$1,930,000 (-102.61%)

$74,002,000 (2103.10%)

Net Cash Flow from Operations

-$16,937,000 (10.84%)

-$18,996,000 (0.45%)

-$19,082,000 (-48.04%)

-$12,890,000 (-5.93%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$11,574,000 (37.79%)

-$18,606,000 (26.77%)

-$25,408,000 (-141.59%)

$61,098,000 (792.88%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

-$4,280,000 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$1,000 (99.50%)

-$202,000 (-74.14%)

-$116,000 (-728.57%)

-$14,000 (-55.56%)

Issuance (Repayment) of Debt Securities

-$67,000 (10.67%)

-$75,000 (94.55%)

-$1,376,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$5,563,000 (150.70%)

$2,219,000 (870.49%)

-$288,000 (-100.39%)

$74,002,000 (2103.10%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$132,000 (-300.00%)

-$33,000 (-3.13%)

-$32,000 (0%)

$0 (0%)

Share Based Compensation

$671,000 (21.56%)

$552,000 (16.21%)

$475,000 (14.18%)

$416,000 (18.86%)

Depreciation Amortization & Accretion

$589,000 (12.62%)

$523,000 (515.29%)

$85,000 (-2.30%)

$87,000 (-56.72%)

TOVX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-101.60% (-136.83%)

-42.90% (-26.92%)

-33.80% (-7.30%)

-31.50% (-109.97%)

Return on Average Assets (ROAA)

-61.60% (-110.24%)

-29.30% (-17.67%)

-24.90% (18.89%)

-30.70% (77.34%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-135.60% (-33.33%)

-101.70% (25.55%)

-136.60% (87.19%)

-1066.10% (-187.52%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.09 (75.60%)

-0.38 (-8.65%)

-0.35 (75.79%)

-1.43 (-147.07%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.26 (28.79%)

0.2 (42.45%)

0.14 (-74.73%)

0.55 (134.25%)

Debt to Equity Ratio (D/E)

0.85 (103.33%)

0.42 (25.75%)

0.33 (339.47%)

0.08 (111.50%)

Earnings Per Share (EPS)

-19.03 (-1569.30%)

-1.14 (12.98%)

-1.31 (31.05%)

-1.9 (71.21%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-12.56 (-954.03%)

-1.19 (4.87%)

-1.25 (-18.32%)

-1.06 (83.47%)

Book Value Per Share (BVPS)

14.14 (516.25%)

2.29 (-32.14%)

3.38 (-36.99%)

5.37 (314.08%)

Tangible Assets Book Value Per Share (TABVPS)

26.22 (753.06%)

3.07 (-28.97%)

4.33 (-25.04%)

5.77 (30.52%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

1 (-50.00%)

2 (0.00%)

2 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.4 (-64.57%)

1.11 (-43.80%)

1.98 (-18.72%)

2.44 (1194.62%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

2.15 (-47.23%)

4.07 (-36.93%)

6.45 (-66.72%)

19.38 (624.30%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$16,938,000 (11.77%)

-$19,198,000 (0.00%)

-$19,198,000 (-48.78%)

-$12,904,000 (-5.97%)

Enterprise Value (EV)

-$9,903,714 (54.37%)

-$21,704,907 (47.97%)

-$41,719,121 (-20.52%)

-$34,617,021 (-1679.63%)

Earnings Before Tax (EBT)

-$25,653,000 (-28.34%)

-$19,989,000 (5.31%)

-$21,110,000 (-47.96%)

-$14,267,000 (-42.06%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$25,064,000 (-28.76%)

-$19,466,000 (7.41%)

-$21,025,000 (-48.27%)

-$14,180,000 (-44.08%)

Invested Capital

$17,627,000 (-18.60%)

$21,656,000 (13.55%)

$19,072,000 (1782.72%)

$1,013,000 (426.77%)

Working Capital

$8,696,000 (-57.92%)

$20,665,000 (-46.27%)

$38,460,000 (-41.11%)

$65,304,000 (1214.49%)

Tangible Asset Value

$35,352,000 (-28.61%)

$49,519,000 (-25.35%)

$66,336,000 (-5.73%)

$70,365,000 (736.68%)

Market Capitalization

$4,869,286 (-33.57%)

$7,330,093 (1.72%)

$7,205,879 (-79.95%)

$35,941,979 (369.37%)

Average Equity

$25,247,750 (-40.94%)

$42,746,000 (-27.84%)

$59,236,500 (-19.64%)

$73,711,250 (1953.67%)

Average Assets

$41,645,000 (-33.39%)

$62,524,750 (-22.30%)

$80,471,500 (6.66%)

$75,448,750 (713.86%)

Invested Capital Average

$18,915,000 (-3.75%)

$19,651,000 (27.18%)

$15,451,750 (1054.62%)

$1,338,250 (262.31%)

Shares

2,782,449 (-83.67%)

17,042,765 (7.57%)

15,844,061 (19.99%)

13,204,254 (560.43%)